Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions
US12291528B2 · kind B2 · utility
0Cited by
10References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 9, 2023 |
| Grant date | May 6, 2025 |
| Priority date | — |
| Expiry date | Nov 9, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, methods of inhibiting tropomyosin-related kinase and/or c-FMS, and methods of treating medical diseases and conditions, such as pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.